Tabea Erdmann

1.1k total citations
14 papers, 346 citations indexed

About

Tabea Erdmann is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Tabea Erdmann has authored 14 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Tabea Erdmann's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and CAR-T cell therapy research (3 papers). Tabea Erdmann is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (4 papers) and CAR-T cell therapy research (3 papers). Tabea Erdmann collaborates with scholars based in Germany, Switzerland and United States. Tabea Erdmann's co-authors include Georg Lenz, Kieron Dunleavy, German Ott, Michael Grau, Annette M. Staiger, Kai Kruse, Noèlia Díaz, Juan M. Vaquerizas, Beiying Dai and Wolfgang E. Berdel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Tabea Erdmann

13 papers receiving 343 citations

Peers

Tabea Erdmann
Jacek Marzec United Kingdom
Paul Biggs United Kingdom
Robert Hauptschein United States
Kelly J Morris United Kingdom
Jacek Marzec United Kingdom
Tabea Erdmann
Citations per year, relative to Tabea Erdmann Tabea Erdmann (= 1×) peers Jacek Marzec

Countries citing papers authored by Tabea Erdmann

Since Specialization
Citations

This map shows the geographic impact of Tabea Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tabea Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tabea Erdmann more than expected).

Fields of papers citing papers by Tabea Erdmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tabea Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tabea Erdmann. The network helps show where Tabea Erdmann may publish in the future.

Co-authorship network of co-authors of Tabea Erdmann

This figure shows the co-authorship network connecting the top 25 collaborators of Tabea Erdmann. A scholar is included among the top collaborators of Tabea Erdmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tabea Erdmann. Tabea Erdmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Juilland, Mélanie, Léonardo Scarpellino, Tabea Erdmann, et al.. (2023). Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination. Proceedings of the National Academy of Sciences. 120(52). e2301155120–e2301155120. 2 indexed citations
2.
Xu, Wendan, Philipp Berning, Tabea Erdmann, et al.. (2022). mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma. Leukemia. 37(1). 178–189. 18 indexed citations
3.
Bucher, Philip, Tabea Erdmann, Wendan Xu, et al.. (2019). Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma. Blood. 135(2). 121–132. 27 indexed citations
4.
Gehring, Torben, Tabea Erdmann, Carina Graß, et al.. (2019). MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells. Cell Reports. 29(4). 873–888.e10. 22 indexed citations
5.
Walter, Carolin, Marta Joana Costa Jordão, Mathias Leddin, et al.. (2019). Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophils. Nature Immunology. 20(5). 546–558. 40 indexed citations
6.
Wullenkord, Ramona, Birte Friedrichs, Tabea Erdmann, & Georg Lenz. (2019). Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphoma. Expert Review of Hematology. 12(12). 1053–1062. 10 indexed citations
7.
8.
Dunleavy, Kieron, Tabea Erdmann, & Georg Lenz. (2018). Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma. Cancer Treatment Reviews. 65. 41–46. 47 indexed citations
9.
Díaz, Noèlia, Kai Kruse, Tabea Erdmann, et al.. (2018). Chromatin conformation analysis of primary patient tissue using a low input Hi-C method. Nature Communications. 9(1). 4938–4938. 64 indexed citations
10.
Walter, Carolin, Tabea Erdmann, Eric M. Bindels, et al.. (2018). Temporal autoregulation during human PU.1 locus SubTAD formation. Blood. 132(25). 2643–2655. 13 indexed citations
11.
Vincendeau, Michelle, Tabea Erdmann, Thomas Seeholzer, et al.. (2016). Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. Oncogene. 35(32). 4269–4281. 39 indexed citations
12.
Juilland, Mélanie, Tabea Erdmann, Yara Banz, et al.. (2016). CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas. Blood. 127(14). 1780–1789. 28 indexed citations
13.
Dai, Beiying, et al.. (2016). The molecular pathogenesis of mantle cell lymphoma. Leukemia & lymphoma. 58(7). 1530–1537. 34 indexed citations
14.
Erdmann, Tabea & Georg Lenz. (2015). Molekularbiologie maligner Lymphome. Der Onkologe. 21(10). 905–912.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026